<DOC>
	<DOCNO>NCT00933998</DOCNO>
	<brief_summary>The purpose research study determine Metanx improve sensory neuropathy person Type 2 diabetes . Metanx medical food available prescription physician . It consist L-methylfolate , Pyridoxal 5'-phosphate , Methylcobalamin , active form folate , vitamin B6 , vitamin B12 , respectively . Subjects assign receive Metanx 12 month . Baseline quantitative sensory test do patient receives Metanx . Additional quantitative sensory test do 6 12 month evaluate .</brief_summary>
	<brief_title>Restoration Cutaneous Sensorum Patients With Diabetic Peripheral Neuropathy ( DPN ) Via MetanxÂ®</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pyridoxal Phosphate</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<criteria>Consecutive diabetic patient enter office ( private practice ) Subjective symptom numbness , burn , paresthesia , etc . Failed Monofilament least two point foot Abnormal PSSD study Willing participate protocol study Taking one Metanx tablet bid 2 week one Metanx tablet daily Keep schedule appointment follow study Report medical intervention , study , medication change Report problem medical psychosocial matter investigator HgbA1c NOT monitor specific value require participation History back problem ( Surgery ECSI ) large fiber neuropathy History chemotherapy History chemical exposure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>DPN</keyword>
</DOC>